Niagen Bioscience, Inc. - COM NEW (NAGE)

Historical Holders from Q1 2016 to Q1 2025

Symbol
NAGE on Nasdaq
CUSIP
171077407
Type / Class
Equity / COM NEW
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
22.4M
Holdings value
$119M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
121
Number of buys
71
Number of sells
-30
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Niagen Bioscience, Inc. - COM NEW (NAGE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 199K $1.38M +$123K $6.90 8
2024 Q4 22.4M $119M +$25.4M $5.31 121
2024 Q3 17.6M $64.3M +$3.09M $3.65 90
2024 Q2 16.5M $45.1M +$8.63M $2.73 78
2024 Q1 13.1M $45.7M +$5.57M $3.48 65
2023 Q4 11.4M $16.2M +$339K $1.43 50
2023 Q3 11M $16.1M +$44.8K $1.46 51
2023 Q2 11.1M $17.4M -$924K $1.57 52
2023 Q1 11.7M $18M +$712K $1.53 54
2022 Q4 11.3M $19M -$424K $1.68 55
2022 Q3 11.1M $13.7M -$3.9M $1.23 53
2022 Q2 15M $25.1M -$9.23M $1.67 65
2022 Q1 20.2M $49.8M -$709K $2.46 77
2021 Q4 20.1M $75.6M -$3.64M $3.74 77
2021 Q3 20.4M $128M -$793K $6.27 82
2021 Q2 20.4M $201M -$22.3M $9.86 97
2021 Q1 22.4M $209M +$69.5M $9.34 92
2020 Q4 15.8M $75.9M +$2.92M $4.80 79
2020 Q3 12.8M $51.3M +$3.48M $4.01 71
2020 Q2 14.1M $64.9M +$6.48M $4.59 64
2020 Q1 10.6M $34.4M +$815K $3.26 58
2019 Q4 12.7M $54.7M +$1.96M $4.31 63
2019 Q3 11.6M $45.6M +$2.34M $3.94 59
2019 Q2 11M $51.1M +$5.2M $4.65 56
2019 Q1 10.1M $42.1M +$2.29M $4.19 56
2018 Q4 9.52M $32.7M -$437K $3.43 56
2018 Q3 9.54M $40.9M +$2.59M $4.29 64
2018 Q2 8.94M $33.2M +$8.1M $3.71 63
2018 Q1 6.6M $27.7M +$3.27M $4.20 57
2017 Q4 5.63M $33M +$13.9M $5.88 51
2017 Q3 3.29M $14.2M -$2.11M $4.30 40
2017 Q2 3.85M $14.7M -$3.74M $3.82 44
2017 Q1 5.05M $13.6M +$4.34M $2.69 45
2016 Q4 4.61M $15.3M +$829K $3.31 52
2016 Q3 4.37M $13M +$976K $2.98 48
2016 Q2 3.98M $16.5M +$16.5M $4.14 46
2016 Q1 10K $14K +$14K $1.40 1